Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07019519

POTS-FLOW: Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Interplay Between Gut Hormones and Autonomic Postprandial Blood Flow Regulation in Patients With POTS

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
30 (estimated)
Sponsor
University of Copenhagen · Academic / Other
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

This study will describe the interplay between the gut hormones GIP and CCK and their regulation of blood flow to the large vessels in patients with Postural Orthostatic Tachycardia Syndrome (POTS) and GIP, CCK and GLP-1 in healthy. This is addressed by hormone infusions during MR-scans of the abdomen and intake of oral glucose.

Detailed description

Each participant will attend independent randomized experimental days with MR-scans during and intravenous infusions of hormones or placebo and ingestion of glucose or water. A continuous intravenous infusion of either GIP(3-30)NH2, CCK8- or saline for POTS-group or GIP(3-30)NH2, CCK-8, saline or exendin(9-39)NH2 in healthy is started while the participant lie in the scanner while scans, blood samples and questionnaires are repeated over the time course of 2 hours. At a specific timepoint the participants will ingest 75 g of glucose dissolved in 250 ml water.

Conditions

Interventions

TypeNameDescription
OTHERSaline/PlaceboNaCl(9mg/ml)
OTHERGIPR antagonistGIP(3-30)NH2
OTHERGLP-1R antagonistGLP-1(9-39)NH2
OTHERCCK agonistCCK-8

Timeline

Start date
2025-03-15
Primary completion
2026-06-30
Completion
2026-09-30
First posted
2025-06-13
Last updated
2025-06-13

Locations

1 site across 1 country: Denmark

Source: ClinicalTrials.gov record NCT07019519. Inclusion in this directory is not an endorsement.